Clinical trial
Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in…
NCT00426998 · Retinal Consultants Medical Group, Other · Completed
Key facts
| NCT number | NCT00426998 |
|---|---|
| Title | Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD |
| Official title | A 24 Month Randomized, Double-Masked, Single Center, Phase II Study Comparing Photodynamic Therapy With Verteporfin (Visudyne)Plus Two Different Timing Regimens of Intravitreal Bevacizumab (Avastin) Given 1 Week Prior to or 1 Week Following Photodynamic Therapy in Patients With Subfoveal Choroidal… |
| Lead sponsor | Retinal Consultants Medical Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Choroidal Neovascularization, Macular Degeneration |
| Intervention type | Drug |
| Interventions | Verteporfin, Bevacizumab |
| Enrollment | 30 |
| Start date | Apr 1, 2006 |
| First posted | Jan 26, 2007 |
| Last update posted | Jan 26, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: